S

S.R. One Ltd

36 employees

SR One is the corporate venture capital arm of GlaxoSmithKline.

Investor insights

Sectors invested in

Biotechnology112
Health Care66
Therapeutics48
Medical39
Pharmaceutical30
Life Science28
Biopharma22
Medical Device19
Genetics12
Health Diagnostics10
oncology10
Clinical Trials8
cancer8
mHealth7
Drug Discovery6
Drug Development5
Peptide Therapeutics5
Phage Display5
ubiquitin5
deubiquitylating enzymes5

Funding rounds participated in

$2.8M sweet spot round size

Most of their 162 investments are in rounds between $18M and $52M

Investor type

Corporate Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Financial Services
Finance
Health Care
Venture Capital

Date founded

2020

Investments made

A

Avalyn Pharma Inc. raised $175M on September 27, 2023

Investors: Surveyor Capital, Vida Ventures, LLC, Novo Holdings, Wellington Management, RiverVest Venture Partners, Perceptive Advisors and S.R. One Ltd

U

Undisclosed raised $210M on September 6, 2023

Investors: GV, Atlas Venture, RA Capital Management, L.P., Lightstone Ventures and S.R. One Ltd

F

Fore Biotherapeutics raised $75M on August 23, 2023

Investors: Medicxi, OrbiMed Advisors, 3B Future Health Fund, Wellington Management, HBM Partners AG and S.R. One Ltd

P

PULMOCIDE LIMITED raised $52M on December 6, 2022

Investors: 旭化成ファーマ(株), Vivo Capital, JEITO, F-Prime Capital Partners, Longwood Fund, IP Group plc, SV Life Sciences and S.R. One Ltd

R

Rezo Therapeutics raised $78M on November 17, 2022

Investors: UCSF Foundation Investment Company, Hawktail, SV Angel, Andreessen Horowitz, Norwest Venture Partners, Liquid 2 Ventures and S.R. One Ltd

O

Odyssey Therapeutics raised $168M on October 13, 2022

Investors: Walleye Capital, SVB Securities, Logos Global Management, LP, General Catalyst, OrbiMed Advisors, Woodline Partners LP, GreatPoint Ventures, T. Rowe Price and S.R. One Ltd

U

Undisclosed raised $125M on September 12, 2022

Investors: SV Life Sciences, Lightstone Ventures, RA Capital Management, L.P., Atlas Venture and S.R. One Ltd

M

MiroBio Ltd raised $97M on June 29, 2022

Investors: Monograph Capital, Oxford Sciences Innovation, OrbiMed Advisors, Advent Life Sciences, Samsara BioCapital, Medicxi and S.R. One Ltd

A

Ancora Biotech raised $60M on June 18, 2022

Investors: Lightspeed Venture Partners and S.R. One Ltd

D

Dren Bio, Inc. raised $65M on June 14, 2022

Investors: HBM Partners AG, Revelation Partners, Mission BioCapital and S.R. One Ltd

FAQ